CAN
INO icon

Cetera Advisor Networks’s Inovio Pharmaceuticals INO Stock Holding History

Cetera Advisor Networks’s Portfolio INO Stock Details INO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-855
Closed -$5.23K – 2865
2023
Q4 		$5.23K Sell
855
-251
-23% -$1.24K ﹤0.01% 2764
2023
Q3 		$5.17K Buy
1,106
+139
+14% +$768 ﹤0.01% 2693
2023
Q2 		$5.18K Sell
967
-10
-1% -$81 ﹤0.01% 2586
2023
Q1 		$9.62K Hold
977
– – ﹤0.01% 2557
2022
Q4 		$18.3K Buy
+977
New +$22.1K ﹤0.01% 2487
2020
Q3 		– Sell
-611
Closed -$198K – 2089
2020
Q2 		$198K Buy
+611
New +$98.1K 0.01% 1129

Other funds holding INO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SFI
Susquehanna Fundamental Investments Bala Cynwyd, Pennsylvania $2.67B AUM 21.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Cetera Advisor Networks's INO Position: Q1 2024 in Review

Cetera Advisor Networks sold out of Inovio Pharmaceuticals (INO) in Q1 2024, closing a stake of 855 shares — an estimated $5.23K sold.

Cetera Advisor Networks first reported a position in INO in Q2 2020 and held it in 6 quarters. The position peaked at $198K in Q2 2020. 89 funds tracked by Wall St. Rank hold INO as of Q1 2024.

  • Cetera Advisor Networks reported no remaining Inovio Pharmaceuticals position as of Q1 2024 after selling out during the quarter.
  • Cetera Advisor Networks sold 855 Inovio Pharmaceuticals shares in Q1 2024, an estimated $5.23K.
  • Cetera Advisor Networks first reported a position in Inovio Pharmaceuticals in Q2 2020 and held it in 6 quarters.
  • Cetera Advisor Networks's Inovio Pharmaceuticals position peaked at $198K in Q2 2020.
  • 89 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q1 2024.

Based on Cetera Advisor Networks's 13F filing for Q1 2024, filed 15 May 2024.